Regge trajectory relation for the universal description of the heavy-heavy systems: Diquarks, mesons, baryons and tetraquarks
Nuclear Physics A · 2024-10 · 1050 · 122927
DOI: 10.1016/j.nuclphysa.2024.122927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuclear Physics A, 2024-10. Verfasst von Jiao-Kai Chen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
By employing the nonlinear Regge trajectory relation $M=m_R+\beta_x(x+c_{0x})^{2/3}\,\,(x=l,\,n_r)$, we investigate the heavy-heavy systems, such as the doubly heavy diquarks, the doubly heavy mesons, the heavy-heavy baryons, and the heavy-heavy tetraquarks. The fitted Regge trajectories illustrate that these heavy-heavy systems satisfy the above formula and show the existence of an universal description of the heavy-heavy systems. The universality embodies not only the universal behavior $M{\sim}x^{2/3}$ but also the universal parameters. The values of $c_{fn_r}$ and $c_{fl}$ vary with different heavy-heavy systems, but they are close to one. There is an inequality $\beta_{n_r}>\beta_{l}$, and it holds for all the discussed heavy-heavy systems. Moreover, the expression of $\beta_x$ [Eq. (11)] explains its variation with the change of the constituents' masses.
Zitieren
APA
Chen, J. (2024). Regge trajectory relation for the universal description of the heavy-heavy systems: Diquarks, mesons, baryons and tetraquarks. Nuclear Physics A, 1050, 122927. https://doi.org/10.1016/j.nuclphysa.2024.122927
Vancouver
Chen J. Regge trajectory relation for the universal description of the heavy-heavy systems: Diquarks, mesons, baryons and tetraquarks. Nuclear Physics A. 2024;1050:122927. doi:10.1016/j.nuclphysa.2024.122927
BibTeX
@article{Chen2024,
author = {Chen, Jiao-Kai},
title = {Regge trajectory relation for the universal description of the heavy-heavy systems: Diquarks, mesons, baryons and tetraquarks},
journal = {Nuclear Physics A},
year = {2024},
volume = {1050},
pages = {122927},
doi = {10.1016/j.nuclphysa.2024.122927}
}
EUVIMED